InvestorsHub Logo
Followers 37
Posts 2960
Boards Moderated 0
Alias Born 01/14/2003

Re: Birdbrain Ideas post# 365340

Tuesday, 01/04/2022 8:50:04 PM

Tuesday, January 04, 2022 8:50:04 PM

Post# of 425648
"Looking through my rose-colored investor's glasses, the ruling can be cheered by Amarin and waved in the face of every insurance company and pharmacy that tries to use formulary selection and the prior authorization process to screw Amarin out of Vascepa sales. "

could also lead to both branded and generic icosapent ethyl being entirely removed from formularies. No coverage for either branded or generic would also lead to no infringement.

It's the ratio, baby ... the EPA/AA ratio!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News